[Therapeutic effect of anti-anaphylaxis granule on chronic urticaria and its impact on serum levels of RANTES]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Oct;29(10):925-8.
[Article in Chinese]

Abstract

Objective: To investigate the therapeutic effect of Anti-anaphylaxis Granule (AAG) on chronic urticaria and its impact on cytokine of regulated upon activation of normal T cells expressed and secreted (RANTES), eosinophil chemotactic factor (Eotaxin) and tumor necrosis factor-alpha (TNF-alpha).

Methods: The therapeutic effects of AAG and cetirizine on chronic urticaria patients allocated in two groups were observed respectively, and the serum levels of RANTES, Eotaxin and TNF-alpha in patients were measured by ELISA before and after treatment, and were compared with those in normal subjects.

Results: The therapeutic effects of AAG group were better in effective rate (88.5% vs 64.0%) and lower in the recurrent rate (5.6% vs 41.9%) than those cetirizine (all P<0.05). Serum levels of RANTES, Eotaxin and TNF-alpha in patients were higher than those in normal subjects (P<0.01), and they could be significantly reduced after AAG treatment (P<0.01).

Conclusion: AAG has favorite effect for treatment of chronic urticaria, its regulation on serum levels of RANTES, Eotaxin and TNF-alpha may be the mechanism of action.

Publication types

  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Cetirizine / therapeutic use
  • Chemokine CCL11 / blood
  • Chemokine CCL5 / blood*
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phytotherapy*
  • Serum / metabolism
  • Tumor Necrosis Factor-alpha / blood
  • Urticaria / blood*
  • Urticaria / drug therapy*
  • Young Adult

Substances

  • CCL5 protein, human
  • Chemokine CCL11
  • Chemokine CCL5
  • Drugs, Chinese Herbal
  • Tumor Necrosis Factor-alpha
  • Cetirizine